HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bente Halvorsen Selected Research

Carotid Artery Diseases

12/2020N6-methyladenosine in RNA of atherosclerotic plaques: An epitranscriptomic signature of human carotid atherosclerosis.
10/2020Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
1/2020Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages.
7/2017Increased expression of TFPI in human carotid stenosis.
1/2017Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARĪ³-Dependent Monocyte Differentiation and Function.
1/2017Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation.
1/2017Increased levels of legumain in plasma and plaques from patients with carotid atherosclerosis.
4/2016The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
1/2016Enhanced base excision repair capacity in carotid atherosclerosis may protect nuclear DNA but not mitochondrial DNA.
3/2015Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bente Halvorsen Research Topics

Disease

61Inflammation (Inflammations)
11/2022 - 10/2003
60Atherosclerosis
03/2022 - 07/2002
27Atherosclerotic Plaque (Atheroma)
10/2021 - 07/2002
18Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 11/2003
16Carotid Artery Diseases
12/2020 - 08/2010
12Acute Coronary Syndrome
10/2020 - 07/2002
12Coronary Artery Disease (Coronary Atherosclerosis)
10/2019 - 07/2002
11Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
11/2021 - 01/2006
11Myocardial Infarction
01/2020 - 03/2004
9Heart Failure
08/2021 - 03/2004
8Ischemic Stroke
01/2020 - 07/2006
7Carotid Stenosis (Carotid Artery Stenosis)
03/2022 - 12/2007
7Hypoxia (Hypoxemia)
01/2019 - 11/2004
6Type 2 Diabetes Mellitus (MODY)
11/2022 - 03/2005
6Thrombosis (Thrombus)
05/2022 - 04/2006
6Insulin Resistance
12/2020 - 01/2009
6Necrosis
12/2020 - 10/2009
6Unstable Angina
01/2013 - 07/2002
5Neoplasms (Cancer)
01/2020 - 04/2010
5Non-alcoholic Fatty Liver Disease
07/2015 - 09/2009
4Fibrosis (Cirrhosis)
11/2022 - 09/2009
4ST Elevation Myocardial Infarction
06/2022 - 01/2013
4Respiratory Insufficiency (Respiratory Failure)
05/2022 - 10/2020
4Obesity
12/2020 - 10/2010
4Stable Angina
10/2020 - 07/2002
4Non-ST Elevated Myocardial Infarction
01/2019 - 01/2018
3Common Variable Immunodeficiency
01/2022 - 04/2005
3Hepatocellular Carcinoma (Hepatoma)
01/2020 - 09/2009
3Stroke (Strokes)
01/2020 - 09/2011
3Pulmonary Hypertension
01/2019 - 04/2009
3Infections
01/2016 - 04/2005
3Homozygous Familial Hypercholesterolemia
03/2013 - 11/2012
3Acromegaly
04/2012 - 12/2009
3Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2012 - 01/2009
2COVID-19
05/2022 - 10/2020
2Thrombocytopenia (Thrombopenia)
05/2022 - 10/2021
2Disease Progression
03/2022 - 03/2015
2Falciparum Malaria (Plasmodium falciparum Malaria)
10/2021 - 01/2020
2Parasitemia
10/2021 - 01/2020
2Malaria
10/2021 - 01/2020
2Coinfection
10/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

29CytokinesIBA
10/2021 - 03/2004
24LipidsIBA
03/2022 - 02/2005
20Messenger RNA (mRNA)IBA
01/2021 - 07/2002
17Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
16CholesterolIBA
12/2021 - 04/2006
15ChemokinesIBA
01/2021 - 07/2002
13Biomarkers (Surrogate Marker)IBA
11/2022 - 11/2008
13InterleukinsIBA
06/2022 - 10/2003
9Apolipoproteins E (ApoE)IBA
10/2021 - 04/2006
8Glucose (Dextrose)FDA LinkGeneric
11/2022 - 01/2010
8RNA (Ribonucleic Acid)IBA
06/2022 - 07/2004
8Interleukin-6 (Interleukin 6)IBA
06/2022 - 01/2010
8oxidized low density lipoproteinIBA
11/2021 - 11/2005
8EnzymesIBA
12/2020 - 08/2010
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 07/2005
8Matrix Metalloproteinases (MMPs)IBA
01/2014 - 11/2004
7LigandsIBA
01/2021 - 07/2004
7Complement System Proteins (Complement)IBA
01/2021 - 10/2011
7InflammasomesIBA
12/2020 - 01/2016
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2020 - 10/2006
6Nicotinamide PhosphoribosyltransferaseIBA
01/2017 - 02/2007
6activin AIBA
05/2011 - 03/2004
5tocilizumab (atlizumab)FDA Link
06/2022 - 01/2018
5LDL Lipoproteins (beta Lipoproteins)IBA
11/2021 - 10/2011
5LDL CholesterolIBA
10/2020 - 03/2006
5Interleukin-10 (Interleukin 10)IBA
01/2011 - 02/2005
5Interleukin-8 (Interleukin 8)IBA
05/2010 - 07/2002
4C-Reactive ProteinIBA
08/2019 - 09/2011
4Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2019 - 01/2018
4Triglycerides (Triacylglycerol)IBA
06/2017 - 04/2006
3Troponin T (Troponin T1)IBA
06/2022 - 09/2011
3Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 01/2014
3Interleukin-27 (Interleukin 27)IBA
10/2021 - 01/2017
3Carrier Proteins (Binding Protein)IBA
10/2021 - 07/2004
3Interleukin-18 (Interleukin 18)IBA
10/2021 - 01/2016
3DNA Glycosylases (DNA Glycosylase)IBA
10/2021 - 01/2016
3trimethyloxamine (trimethylamine N-oxide)IBA
08/2021 - 04/2016
3Lipoprotein(a)IBA
01/2021 - 01/2019
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2021 - 03/2004
3Oxygen (Dioxygen)IBA
01/2021 - 01/2016
3asparaginylendopeptidase (legumain)IBA
01/2020 - 01/2017
3Cysteine Proteases (Cysteine Protease)IBA
01/2020 - 01/2017
3OsteoprotegerinIBA
08/2019 - 05/2005
3lipoprotein-associated coagulation inhibitor (TFPI)IBA
07/2017 - 01/2016
3Insulin (Novolin)FDA Link
10/2016 - 12/2009
3InterferonsIBA
01/2016 - 05/2010
3Toll-Like Receptors (Toll-Like Receptor)IBA
05/2012 - 08/2010
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2010 - 07/2002
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2010 - 12/2009
3CollagenIBA
11/2008 - 07/2005
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2008 - 07/2002
3HomocysteineIBA
11/2008 - 11/2003
2Metformin (Glucophage)FDA LinkGeneric
11/2022 - 03/2012
2N-methyladenosineIBA
01/2022 - 12/2020
2Lipoproteins (Lipoprotein)IBA
11/2021 - 11/2017
2Lipopolysaccharide ReceptorsIBA
01/2021 - 01/2018

Therapy/Procedure

10Therapeutics
01/2022 - 10/2006
3Blood Component Removal (Apheresis)
03/2013 - 11/2012
3Immunomodulation
11/2005 - 07/2005